Current state of biologics in treating eosinophilic esophagitis
Jan 1, 2023 · Eosinophilic esophagitis (EoE) is a chronic, allergen-mediated, eosinophil-predominant, type 2 inflammatory disease that progresses to fibrostenosis of the esophagus if …
Biologics in the Treatment of Eosinophilic Esophagitis: Ready for …
Sep 15, 2023 · Eosinophilic esophagitis (EoE) is a chronic disease mediated by environmental allergens and type 2 immune inflammation, which causes significant symptoms including …
Biologics for eosinophilic oesophagitis: a systematic review
Dec 21, 2024 · However, the discussion of biologics in non-pharyngitis EGID is hampered by a lack of research, necessitating more research in high-quality trials. Keywords: Eosinophilic …
Full article: Biologics for eosinophilic oesophagitis: a systematic ...
Dec 21, 2024 · Objective Advancing the understanding of the pathophysiology of eosinophilic oesophagitis (EoE) and other eosinophilic gastrointestinal diseases (EGIDs) has spurred …
Consumer’s Guide to Biologics for Eosinophilic Esophagitis
Feb 20, 2024 · Wondering if you should take a biologic medication to treat eosinophilic esophagitis? Here’s what you should know about this innovative drug class.
Long-term treatment in eosinophilic esophagitis: continue, taper, …
3 days ago · Eosinophilic esophagitis (EoE) is a chronic, immune-mediated disorder characterized by symptoms of esophageal dysfunction together with histological evidence of eosinophilic …
Biologics in Eosinophilic Esophagitis — Ready for Prime Time?
Dec 21, 2022 · Eosinophilic esophagitis is an immune-mediated, chronic, inflammatory disease of the esophagus that was first recognized as a distinct entity less than three decades ago.1 The …
Potential therapeutic target for mucosal healing in eosinophilic ...
4 days ago · Researchers at Children's Hospital of Philadelphia (CHOP) identified a potential new therapeutic target for eosinophilic esophagitis (EoE), a chronic allergic inflammatory disease of …
Eosinophilic esophagitis: promising therapy, biomarkers, and …
Feb 25, 2023 · The recent approval of dupilumab for treatment of eosinophilic esophagitis (EOE), research into better biomarkers, and the anticipated availability of a metric to assess EOE …
Evolution of EoE Pharmacologic Therapies – May 2025
Explore the evolution of pharmacologic treatments for eosinophilic esophagitis (EoE), including proton pump inhibitors, topical corticosteroids, and biologic agents, highlighting advancements …